Roger G. Deeley
#156,400
Most Influential Person Now
Roger G. Deeley's AcademicInfluence.com Rankings
Roger G. Deeleymedical Degrees
Medical
#3066
World Rank
#3517
Historical Rank
Pharmacology
#360
World Rank
#411
Historical Rank
Roger G. Deeleybiology Degrees
Biology
#12076
World Rank
#15526
Historical Rank
Biochemistry
#2036
World Rank
#2178
Historical Rank
Download Badge
Medical Biology
Why Is Roger G. Deeley Influential?
(Suggest an Edit or Addition)Roger G. Deeley's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. (2005) (1311)
- The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. (1994) (861)
- Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. (1994) (818)
- Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. (2006) (740)
- Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. (1994) (678)
- Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. (1996) (544)
- The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. (2004) (501)
- Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. (1998) (414)
- Structural, mechanistic and clinical aspects of MRP1. (1999) (403)
- Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. (2001) (386)
- Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP (1998) (377)
- Biology of the multidrug resistance-associated protein, MRP. (1996) (372)
- Transport of glutathione and glutathione conjugates by MRP1. (2006) (332)
- ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) (1996) (271)
- Substrate recognition and transport by multidrug resistance protein 1 (ABCC1) (2006) (270)
- Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. (1996) (249)
- Primary activation of the vitellogenin gene in the rooster. (1977) (238)
- Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. (2001) (230)
- Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. (2001) (224)
- Membrane Topology of the Multidrug Resistance Protein (MRP) (1997) (212)
- Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. (1994) (212)
- Vitellogenin synthesis in the avian liver. Vitellogenin is the precursor of the egg yolk phosphoproteins. (1975) (198)
- ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. (1997) (186)
- Comparison of the Functional Characteristics of the Nucleotide Binding Domains of Multidrug Resistance Protein 1* (2000) (183)
- Glutathione Stimulates Sulfated Estrogen Transport by Multidrug Resistance Protein 1* (2001) (173)
- Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. (1999) (171)
- Function, evolution and structure of multidrug resistance protein (MRP). (1997) (166)
- Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. (1993) (157)
- Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). (2000) (155)
- Mutation of a Single Conserved Tryptophan in Multidrug Resistance Protein 1 (MRP1/ABCC1) Results in Loss of Drug Resistance and Selective Loss of Organic Anion Transport* (2001) (155)
- Reconstitution of ATP-dependent Leukotriene C4 Transport by Co-expression of Both Half-molecules of Human Multidrug Resistance Protein in Insect Cells* (1996) (155)
- Transport of the β-O-Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1) (2001) (150)
- The Structure of the Multidrug Resistance Protein 1 (MRP1/ABCC1) (2001) (144)
- Characterization of the Mr 190,000 Multidrug Resistance Protein (MRP) in Drug-selected and Transfected Human Tumor Cells (1995) (144)
- Coordinate regulation of two estrogen-dependent genes in avian liver. (1980) (142)
- Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. (1997) (141)
- Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. (2001) (123)
- Multidrug Resistance Protein (1998) (122)
- Effects of estrogen on apolipoprotein secretion by the human hepatocarcinoma cell line, HepG2. (1985) (122)
- Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). (2003) (117)
- Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. (1996) (115)
- A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. (2002) (114)
- Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. (1995) (112)
- Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. (1996) (110)
- The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. (1995) (107)
- Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. (1992) (105)
- Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. (1997) (99)
- Functional Reconstitution of Substrate Transport by Purified Multidrug Resistance Protein MRP1 (ABCC1) in Phospholipid Vesicles* (2000) (97)
- ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells. (1999) (96)
- Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. (2005) (90)
- Identification of an Amino Acid Residue in Multidrug Resistance Protein 1 Critical for Conferring Resistance to Anthracyclines* (2001) (90)
- Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution (2001) (86)
- Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA. (1997) (86)
- Monoclonal Antibodies That Inhibit the Transport Function of the 190-kDa Multidrug Resistance Protein, MRP (1999) (84)
- Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ABCC1 in protein processing and trafficking. (2005) (84)
- Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1) (2005) (81)
- Role of Carboxylate Residues Adjacent to the Conserved Core Walker B Motifs in the Catalytic Cycle of Multidrug Resistance Protein 1 (ABCC1)* (2003) (80)
- Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C and Chemotherapeutic Agents in Membrane Vesicles (1996) (80)
- Cloning and characterization of chicken YB-1: regulation of expression in the liver (1993) (80)
- Kinetics of avian vitellogenin messenger RNA induction. Comparison between primary and secondary response to estrogen. (1977) (79)
- Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP). (1998) (78)
- Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). (2004) (76)
- Charged Amino Acids in the Sixth Transmembrane Helix of Multidrug Resistance Protein 1 (MRP1/ABCC1) Are Critical Determinants of Transport Activity* (2002) (73)
- Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1). (2008) (71)
- Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions* (2004) (69)
- Identification of a Nonconserved Amino Acid Residue in Multidrug Resistance Protein 1 Important for Determining Substrate Specificity (2001) (67)
- Molecular Modeling Correctly Predicts the Functional Importance of Phe594 in Transmembrane Helix 11 of the Multidrug Resistance Protein, MRP1 (ABCC1)* (2004) (66)
- Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1). (2003) (65)
- Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone. (1986) (63)
- Multidrug resistance-associated protein: sequence correction. (1993) (62)
- ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells. (2006) (62)
- Characterization of Binding of Leukotriene C4 by Human Multidrug Resistance Protein 1 (2001) (60)
- Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. (2001) (60)
- Localization of a Substrate Specificity Domain in the Multidrug Resistance Protein* (1999) (60)
- cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA. (1995) (60)
- Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3' untranslated region. (1998) (59)
- Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1)* (2006) (57)
- ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. (1996) (57)
- Estrogen memory effect in human hepatocytes during repeated cell division without hormone. (1986) (56)
- Estrogen-dependent activation of the avian very low density apolipoprotein II and vitellogenin genes. Transient alterations in mRNA polyadenylation and stability early during induction. (1988) (56)
- Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. (1986) (53)
- GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776 (2002) (51)
- Structural Requirements for Functional Interaction of Glutathione Tripeptide Analogs with the Human Multidrug Resistance Protein 1 (MRP1) (2003) (50)
- Structure-activity studies of verapamil analogs that modulate transport of leukotriene C(4) and reduced glutathione by multidrug resistance protein MRP1. (2000) (50)
- Cloning of a double-stranded cDNA that codes for a portion of chicken preproalbumin. A general method for isolating a specific DNA sequence from partially purified mRNA. (1978) (50)
- Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. (1995) (50)
- Identification of Regions Required for Apical Membrane Localization of Human Multidrug Resistance Protein 2 (2008) (50)
- Differences between the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor in human hepatoma cells and fibroblasts reside primarily at the translational and post-translational levels. (1991) (49)
- Determinants of the Substrate Specificity of Multidrug Resistance Protein 1 (2002) (49)
- Multiple Membrane-associated Tryptophan Residues Contribute to the Transport Activity and Substrate Specificity of the Human Multidrug Resistance Protein, MRP1* (2002) (49)
- Functional Importance of Three Basic Residues Clustered at the Cytosolic Interface of Transmembrane Helix 15 in the Multidrug and Organic Anion Transporter MRP1 (ABCC1)* (2006) (48)
- Photolabeling of Human and Murine Multidrug Resistance Protein 1 with the High Affinity Inhibitor [125I]LY475776 and Azidophenacyl-[35S]Glutathione* (2002) (47)
- Identification of the structural and functional boundaries of the multidrug resistance protein 1 cytoplasmic loop 3. (2003) (46)
- Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein (1994) (46)
- Molecular Basis for Reduced Estrone Sulfate Transport and Altered Modulator Sensitivity of Transmembrane Helix (TM) 6 and TM17 Mutants of Multidrug Resistance Protein 1 (ABCC1) (2009) (45)
- Functional Importance of Polar and Charged Amino Acid Residues in Transmembrane Helix 14 of Multidrug Resistance Protein 1 (MRP1/ABCC1) (2003) (45)
- A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. (1998) (44)
- Mutational Analysis of Ionizable Residues Proximal to the Cytoplasmic Interface of Membrane Spanning Domain 3 of the Multidrug Resistance Protein, MRP1 (ABCC1) (2004) (42)
- Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. (1997) (40)
- Structural Determinants of Substrate Specificity Differences between Human Multidrug Resistance Protein (MRP) 1 (ABCC1) and MRP3 (ABCC3) (2008) (40)
- Apolipoprotein C-II mRNA levels in primate liver. Induction by estrogen in the human hepatocarcinoma cell line, HepG2. (1985) (39)
- Differential induction of the serum amyloid A gene family in response to an inflammatory agent and to amyloid-enhancing factor. (1989) (39)
- Chicken sterol carrier protein 2/sterol carrier protein x: cDNA cloning reveals evolutionary conservation of structure and regulated expression. (1993) (38)
- Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. (2003) (36)
- Transport of the b-O-Glucuronide Conjugate of the Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the Multidrug Resistance Protein 1 (MRP1) REQUIREMENT FOR GLUTATHIONE OR A NON-SULFUR-CONTAINING ANALOG* (2001) (35)
- Analysis of Human Multidrug Resistance Protein 1 (ABCC1) by Matrix-Assisted Laser Desorption Ionization/Time of Flight Mass Spectrometry: Toward Identification of Leukotriene C4 Binding Sites (2005) (34)
- Multidrug resistance associated with overexpression of MRP. (1996) (34)
- In vitro translation of avian vitellogenin messenger RNA. (1977) (34)
- The 5' noncoding and flanking regions of the avian very low density apolipoprotein II and serum albumin genes. Homologies with the egg white protein genes. (1983) (34)
- Selective block of albumin gene expression in chick embryo hepatocytes cultured without hormones and its partial reversal by insulin. (1983) (34)
- Functional Expression of the Multidrug Resistance-associated Protein in the Yeast Saccharomyces cerevisiae(*) (1996) (33)
- Modulation of Human Multidrug Resistance Protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) Transport Activities by Endogenous and Exogenous Glutathione-Conjugated Catechol Metabolites (2008) (33)
- An episomal expression vector system for monitoring sequence-specific effects on mRNA stability in human cell lines. (1995) (33)
- Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy. (1998) (32)
- Mechanistic Differences between GSH Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) and GSH Modulation of MRP1-Mediated Transport (2008) (32)
- Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1. (2004) (31)
- Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions. (2003) (31)
- Could poly(A) align the splicing sites of messenger RNA precursors? (1980) (31)
- The Multidrug Resistance Protein 1: A Functionally Important Activation Marker for Murine Th1 Cells1 (2000) (31)
- Induction of vitellogenin synthesis by estrogen in avian liver: relationship between level of vitellogenin mRNA and vitellogenin synthesis. (1976) (30)
- Inhibition of transcription of the histidine operon in vitro by the first enzyme of the histidine pathway. (1973) (30)
- Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3. (2003) (29)
- ATP is not required for anion current activated by cell swelling in multidrug-resistant lung cancer cells. (1994) (29)
- Primary induction of vitellogenin mRNA in the rooster by 17beta-estradiol. (1978) (28)
- Functional Interactions Between Nucleotide Binding Domains and Leukotriene C4 Binding Sites of Multidrug Resistance Protein 1 (ABCC1) (2005) (28)
- Role of two adjacent cytoplasmic tyrosine residues in MRP1 (ABCC1) transport activity and sensitivity to sulfonylureas. (2005) (27)
- Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites. (2005) (26)
- Multiple Roles of Charged Amino Acids in Cytoplasmic Loop 7 for Expression and Function of the Multidrug and Organic Anion Transporter MRP1 (ABCC1) (2009) (26)
- Structure and evolution of primate cytochrome c oxidase subunit II gene. (1987) (26)
- Molecular cloning and pharmacological characterization of rat multidrug resistance protein 1 (mrp1). (2003) (25)
- The effects of estrogen on apolipoprotein synthesis. (1985) (25)
- Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein 1. (2008) (24)
- Structure of a human multidrug transporter in an inward-facing conformation. (2010) (24)
- Long-term effects of estrogen on avian liver: estrogen-inducible switch in expression of nuclear, hormone-binding proteins (1987) (23)
- Effect of estrogen on gene expression: purification of vitellogenin messenger RNA. (1975) (22)
- Organization, sequence and nuclease hypersensitivity of repetitive elements flanking the chicken apoVLDLII gene: extended sequence similarity to elements flanking the chicken vitellogenin gene (1988) (22)
- Mutational Analysis of a Highly Conserved Proline Residue in MRP1, MRP2, and MRP3 Reveals a Partially Conserved Function (2007) (22)
- MUTATIONAL ANALYSIS OF POLAR AMINO ACID RESIDUES WITHIN PREDICTED TRANSMEMBRANE HELICES 10 AND 16 OF MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1): EFFECT ON SUBSTRATE SPECIFICITY (2006) (22)
- CHAPTER 19 – MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1) (2003) (21)
- Mutation of proline residues in the NH(2)-terminal region of the multidrug resistance protein, MRP1 (ABCC1): effects on protein expression, membrane localization, and transport function. (2003) (21)
- The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias. (1996) (20)
- The avian apoprotein II very low density lipoprotein gene. Methylation patterns of 5' and 3' flanking regions during development and following induction by estrogen. (1982) (18)
- Regulation of gene expression in prokaryotic organisms. (1976) (18)
- Specific binding of the first enzyme for histidine biosynthesis to the DNA of histidine operon. (1975) (17)
- Role of proline 1150 in functional interactions between the membrane spanning domains and nucleotide binding domains of the MRP1 (ABCC1) transporter. (2008) (17)
- Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil. (1998) (16)
- Regulation of apolipoprotein A-I gene expression by phenobarbital in the human hepatocarcinoma cell line, Hep3B. (1994) (16)
- Cloning and structural characterization of an estrogen-dependent apolipoprotein gene. (1981) (16)
- Identification and Characterization of Functionally Important Elements in the Multidrug Resistance Protein 1 COOH-terminal Region* (2004) (15)
- Detection and characterization of degradative intermediates of avian apo very low density lipoprotein II mRNA present in estrogen-treated birds and following destabilization by hormone withdrawal. (1989) (15)
- DNA binding and transcription activation by chicken interferon regulatory factor-3 (chIRF-3). (2000) (14)
- Characterization of the estrogen-responsive domain of avian liver and cloning of double-stranded cDNA derived from estrogen-inducible RNA species. (1979) (14)
- 25-Hydroxylation of vitamin D3 in the human hepatoma cell lines Hep G2 and Hep 3B. (1988) (14)
- Isolation and characterization of the chicken homeodomain protein AKR. (1995) (12)
- Cloning and promoter analysis of the chicken interferon regulatory factor-3 gene. (2000) (11)
- Interaction between phosphoribosyltransferase and purified histidine tRNA from wild type Salmonella typhimurium and a derepressed hisT mutant strain. (1975) (11)
- Simultaneous Quantitation of Topoisomerase II α and β Isoform mRNAs in Lung Tumor Cells and Normal and Malignant Lung Tissue (2000) (10)
- Characterization of three distinct size classes of human 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA: expression of the transcripts in hepatic and nonhepatic cells. (1990) (10)
- Developmental regulation of specific protein interactions with an enhancerlike binding site far upstream from the avian very-low-density apolipoprotein II gene (1990) (10)
- Multidrug Resistance II: MRP and Related Proteins (2002) (9)
- Specific transcription in chicken liver chromatin by endogenous RNA polymerase II. Comparison of an estrogen-inducible gene with a constitutively expressed gene. (1979) (9)
- The Effect of Estrogen on Gene Expression in Avian Liver (1980) (9)
- Characterization of protein interactions with positive and negative elements regulating the apoVLDLII gene. (1994) (8)
- Mapping of the MRPm5 epitope to the cytosolic region between transmembrane helices 13 and 14 in the drug and organic anion transporter, MRP1 (ABCC1). (2004) (8)
- Standardization of a single-cell assay for sensitive detection of multidrug resistance protein expression in normal and malignant cells in archival clinical samples. (1997) (7)
- Cloning and Characterization of the Murine and Rat mrp 1 Promoter Regions (2003) (7)
- Molecular Modeling Correctly Predicts the Functional Importance of Phe 594 in Transmembrane Helix 11 of the Multidrug Resistance (2004) (7)
- Estrogen-dependent modification of ribosomal proteins. Effects of estrogen withdrawal on the distribution of constitutive and hormonally regulated mRNAs. (1984) (6)
- Determinants of the DNA-binding specificity of the Avian homeodomain protein, AKR. (1999) (5)
- ATP-dependent transport of aflatoxin B-1 and its glutathione conjugates by the multidrug resistance protein, MRP (1997) (5)
- Effect of Multiple Cysteine Substitutions on the Functionality of Human Multidrug Resistance Protein 1 Expressed in Human Embryonic Kidney 293 Cells: Identification of Residues Essential for Function (2012) (5)
- PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 ( MRP 1 ) (2003) (5)
- Functional expression of the multidrug resistance-associated protein in the yeast Saccharomyces cerevisiae. (1999) (4)
- Synthesis and Deposition of Egg Proteins (2019) (4)
- Outgrowth of Stable Class I Major Histocompatibility Complex‐Expressing Subsets From Immunogenic Variants of a Murine Mammary Carcinoma: Association with a Differentially Staining Region on Chromosome 9 (1991) (4)
- Structural Studies of Multidrug Resistance Protein 1 Using “Almost” Cysless Template (2018) (3)
- Estrogen-dependent Modification of Ribosomal Proteins (1984) (3)
- efflux of oxysterol by intact cells rapid 25-hydroxycholesterol by membrane vesicles and ABCA1 mediates high-affinity uptake of (2006) (3)
- Characterization of liver-enriched proteins binding to a developmentally demethylated site flanking the avian apoVLDLII gene. (1992) (2)
- Biology of MRP in drug resistance of lung cancer (1997) (2)
- Cloning, transfer, and characterization of multidrug resistance protein. (1998) (1)
- ( MRP ) Increases Resistance to Natural Product Drugs Overexpression of Multidrug Resistance-associated Protein Updated (2007) (1)
- ( MRP ) in Drug-selected and Transfected Human Tumor Cells 190 , 000 Multidrug Resistance Proteinr M Characterization of the Updated (2006) (0)
- Advances in Brief Detection of the Mr 190 , 000 MilitidrUg Resistance Protein , MRP , with Monoclonal Antibodies ' (2006) (0)
- Monoclonal antibodies for detection of the 190 kDa multidrug resistance protein, MRP (1995) (0)
- 561 Immunohistochemical detection of the multidrug resistance protein (MRP) in human lung cancer (1997) (0)
- DR 4 and H 69 AR Human Tumor Cell Lines Localization of a Novel Multidrug Resistance-associated Gene (2006) (0)
- Advances in Brief Sequential Coexpression of the Multidrug Resistance Genes MRP and mdrl and Their Products in VP-16 ( Etoposide )-selected H 69 Small Cell Lung Cancer Cells 1 (2006) (0)
- Effect ofestrogen ongeneexpression: Purification ofvitellogenin messenger RNA (1975) (0)
- RESISTANT TUMOR CELLS (2017) (0)
- The Avian Apoprotein I 1 Very Low METHYLATION PATTERNS OF 5 ’ AND 3 ’ FLANKING INDUCTION BY ESTROGEN * Density Lipoprotein Gene REGIONS DURING DEVELOPMENT AND FOLLOWING (2001) (0)
- A multidrug-resistance-protein (MRP)-like transmembrane pump is differentially expressed in resting, but not activated Th1 and Th2 cells (1997) (0)
- Mass Spectrometry: Towards Identification of Leukotriene C4 Binding Sites (2005) (0)
- Gene Amplification LRP or MRP Evidence That Chromosome Breakage Plays a Key Role in on Chromosome 16 : MRP Drug Resistance Maps Proximal to Gene Encoding a Major Vault Protein Associated with LRP The Updated (2006) (0)
- EFFECT OF ESTROGEN ON GENE EXPRESSION: VITELLOGENIN SYNTHESIS MAY BE REGULATED AT THE LEVEL OF BOTH TRANSCRIPTION AND TRANSLATION (1976) (0)
- Apolipoprotein C-I1 mRNA Levels in Primate Liver INDUCTION BY ESTROGEN IN THE HUMAN HEPATOCARCINOMA CELL LINE, (2001) (0)
- Structural studies of Multidrug Resistance Protein 1 ( MRP 1 ) using “ almost ” cysless template (2018) (0)
- Advances in Brief Overexpression of Multidrug Resistance-associated Protein ( MRP ) Increases Resistance to Natural Product Drugs I (2007) (0)
- Multidrug resistance-gen (1993) (0)
- P-Glycoprotein Chemotherapy despite Cyclosporine for Reversal of Retinoblastoma Correlates with the Rare Failure of Multidrug Resistance Protein ( MRP ) Expression in Updated Version (2006) (0)
- Proteine de resistance a des medicaments multiples (1993) (0)
- 559 Energy dependent reduction of cisplatin accumulation in a cisplatin-resistant human small cell lung cancer (SCLC) cell line☆ (1997) (0)
- Purification of a protein binding far upstream of the avian apovldlii gene (1990) (0)
- The effects of estrogen 011 apolipoprotein synthesis (1985) (0)
- Murine Th 1 Cells Functionally Important Activation Marker The Multidrug Resistance Protein 1 : (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Roger G. Deeley?
Roger G. Deeley is affiliated with the following schools:
